Mesoblast Limited
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Mesoblast Limited is publicly traded on NASDAQ under the ticker MESO.
Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. Its global presence extends across the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company addresses a broad spectrum of medical conditions, including cardiovascular, spinal orthopedic disorders, oncology, hematology, and immune-mediated and...
Can you invest in Mesoblast Limited?
Yes. Mesoblast Limited is publicly traded on NASDAQ under the ticker MESO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Mesoblast Limited
Detailed equity research is provided by MarketSnap.